Zhao N, et al
Media description (scene 7): Text bubbles appear between Jason and Frankie, a CVS Weight Management program dietitian
Association of GLP-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases (JAMA Internal Medicine full text)
Pflanzenschutzdienst (DDR), 26 : 245-247 (in German)
Neither is true. However, Terushkin, who was also not part of the study, acknowledged that GLP-1 drugs have absolutely changed the field. In his practice, Terushkin said he has seen patients who have struggled for years with diet, exercise, and medications that didnt work for them, who are now losing weight on drugs like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)
First, niacinamide acts as a stabilizing agent